April 19 (Reuters) - Kalytera Therapeutics Inc KALY.V :
* KALYTERA ANNOUNCES ISSUANCE OF PATENT COVERING THE USE OF CBD FOR THE TREATMENT OF SEVERE AND REFRACTORY GRAFT VERSUS HOST DISEASE
* KALYTERA THERAPEUTICS INC - KALYTERA ALSO EXPECTS TO INITIATE AN ADDITIONAL PHASE 2 CLINICAL STUDY IN TREATMENT OF GVHD LATER THIS YEAR